Home › Stocks › MLYS › All Fund Holders
MLYS — MINERALYS THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 38 · Reported value held: $863.45M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 5.89M | $158.83M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 4.51M | $121.73M | 0.01% | Reduce |
| Vanguard Group history | Q4 2025 | 3.35M | $121.68M | 0.00% | Add |
| Capital World Investors history | Q2 2026 | 2.00M | $53.90M | 0.01% | Add |
| Point72 Asset Management history | Q1 2026 | 1.91M | $51.78M | 0.07% | Add |
| Franklin Resources history | Q2 2026 | 1.64M | $44.13M | 0.01% | Reduce |
| Geode Capital Management history | Q2 2026 | 1.58M | $42.75M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 1.51M | $40.62M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 1.25M | $33.80M | 0.01% | Add |
| Farallon Capital Management history | Q4 2025 | 823.30K | $29.88M | 0.14% | Reduce |
| Invesco Ltd history | Q2 2026 | 1.09M | $29.44M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 917.21K | $24.75M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 806.72K | $21.77M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 551.49K | $14.88M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 521.22K | $14.06M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 378.30K | $10.21M | 0.01% | Reduce |
| UBS Group AG history | Q2 2026 | 361.60K | $9.76M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 352.73K | $9.52M | 0.01% | Reduce |
| Two Sigma Investments history | Q2 2026 | 162.08K | $4.37M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 158.55K | $4.28M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 152.50K | $4.11M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 99.33K | $2.68M | 0.00% | Add |
| Moore Capital Management history | Q4 2025 | 60.00K | $2.18M | 0.03% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 66.06K | $1.78M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 58.88K | $1.59M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 52.60K | $1.42M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 49.62K | $1.40M | 0.00% | New |
| CPP Investments history | Q2 2026 | 51.40K | $1.39M | 0.00% | Hold |
| Legal & General Investment Management America history | Q2 2026 | 38.05K | $1.03M | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 33.90K | $914.62K | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 32.01K | $863.55K | 0.00% | Add |
| Balyasny Asset Management history | Q3 2025 | 15.27K | $578.96K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 19.85K | $537.28K | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 18.00K | $485.64K | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 9.36K | $252.40K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 2.26M | $61.04K | 0.01% | Add |
| PNC Financial Services history | Q2 2026 | 2.23K | $60.27K | 0.00% | Hold |
| Fidelity International (FIL) history | Q2 2026 | 229 | $6.18K | 0.00% | Hold |